Literature DB >> 22038048

Down-regulation of glutatione S-transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection.

Yiorgos Apidianakis1, Yok-Ai Que, Weihong Xu, George P Tegos, Piotr Zimniak, Michael R Hamblin, Ronald G Tompkins, Wenzhong Xiao, Laurence G Rahme.   

Abstract

Patients with severe burns are highly susceptible to bacterial infection. While immunosuppression facilitates infection, the contribution of soft tissues to infection beyond providing a portal for bacterial entry remains unclear. We showed previously that glutathione S-transferase S1 (gstS1), an enzyme with conjugating activity against the lipid peroxidation byproduct 4-hydroxynonenal (4HNE), is important for resistance against wound infection in Drosophila muscle. The importance of the mammalian functional counterpart of GstS1 in the context of wounds and infection has not been investigated. Here we demonstrate that the presence of a burn wound dramatically affects expression of both human (hGSTA4) and mouse (mGsta4) 4HNE scavengers. hGSTA4 is down-regulated significantly within 1 wk of thermal burn injury in the muscle and fat tissues of patients from the large-scale collaborative Inflammation and the Host Response to Injury multicentered study. Similarly, mGsta4, the murine GST with the highest catalytic efficiency for 4HNE, is down-regulated to approximately half of normal levels in mouse muscle immediately postburn. Consequently, 4HNE protein adducts are increased 4- to 5-fold in mouse muscle postburn. Using an open wound infection model, we show that deletion of mGsta4 renders mice more susceptible to infection with the prevalent wound pathogen Pseudomonas aeruginosa, while muscle hGSTA4 expression negatively correlates with burn wound infection episodes per patient. Our data suggest that hGSTA4 down-regulation and the concomitant increase in 4HNE adducts in human muscle are indicative of susceptibility to infection in individuals with severely thermal injuries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038048      PMCID: PMC3290433          DOI: 10.1096/fj.11-192484

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  Catalytic function of Drosophila melanogaster glutathione S-transferase DmGSTS1-1 (GST-2) in conjugation of lipid peroxidation end products.

Authors:  S P Singh; J A Coronella; H Benes; B J Cochrane; P Zimniak
Journal:  Eur J Biochem       Date:  2001-05

2.  Local and distant burn injury alter immuno-inflammatory gene expression in skeletal muscle.

Authors:  Katie E Padfield; Qunhao Zhang; Suresh Gopalan; A Aria Tzika; Michael N Mindrinos; Ronald G Tompkins; Laurence G Rahme
Journal:  J Trauma       Date:  2006-08

3.  Successful treatment of invasive burn wound infection with sepsis in patients with major burns.

Authors:  J Chai; Z Sheng; H Yang; L Diao; L Li
Journal:  Chin Med J (Engl)       Date:  2000-12       Impact factor: 2.628

Review 4.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Optical monitoring and treatment of potentially lethal wound infections in vivo.

Authors:  Michael R Hamblin; Touqir Zahra; Christopher H Contag; Albert T McManus; Tayyaba Hasan
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

6.  The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa.

Authors:  Gee W Lau; Boyan C Goumnerov; Cynthia L Walendziewicz; Jennifer Hewitson; Wenzhong Xiao; Shalina Mahajan-Miklos; Ronald G Tompkins; Lizabeth A Perkins; Laurence G Rahme
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 7.  The use of glutathione transferase-knockout mice as pharmacological and toxicological models.

Authors:  Philip G Board
Journal:  Expert Opin Drug Metab Toxicol       Date:  2007-06       Impact factor: 4.481

Review 8.  Oxidative stress and anti-oxidative mobilization in burn injury.

Authors:  Arti Parihar; Mordhwaj S Parihar; Stephen Milner; Satyanarayan Bhat
Journal:  Burns       Date:  2007-10-01       Impact factor: 2.744

Review 9.  Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy.

Authors:  Jureta W Horton
Journal:  Toxicology       Date:  2003-07-15       Impact factor: 4.221

10.  Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma.

Authors:  Yiorgos Apidianakis; Michael N Mindrinos; Wenzhong Xiao; George P Tegos; Michail I Papisov; Michael R Hamblin; Ronald W Davis; Ronald G Tompkins; Laurence G Rahme
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  17 in total

1.  The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.

Authors:  Aaron B Sullivan; K P Connie Tam; Matteo M E Metruccio; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Prediction of multiple infections after severe burn trauma: a prospective cohort study.

Authors:  Shuangchun Yan; Amy Tsurumi; Yok-Ai Que; Colleen M Ryan; Arunava Bandyopadhaya; Alexander A Morgan; Patrick J Flaherty; Ronald G Tompkins; Laurence G Rahme
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

Review 3.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

Review 4.  Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings.

Authors:  Stavria Panayidou; Eleni Ioannidou; Yiorgos Apidianakis
Journal:  Virulence       Date:  2014-01-07       Impact factor: 5.882

5.  Loss of glutathione S-transferase A4 accelerates obstruction-induced tubule damage and renal fibrosis.

Authors:  Anlin Liang; Yun Wang; Lauren E Woodard; Matthew H Wilson; Rajendra Sharma; Yogesh C Awasthi; Jie Du; William E Mitch; Jizhong Cheng
Journal:  J Pathol       Date:  2012-07-26       Impact factor: 7.996

6.  Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy.

Authors:  Valeria Righi; Caterina Constantinou; Dionyssios Mintzopoulos; Nadeem Khan; S P Mupparaju; Laurence G Rahme; Harold M Swartz; Hazel H Szeto; Ronald G Tompkins; A Aria Tzika
Journal:  FASEB J       Date:  2013-03-12       Impact factor: 5.191

7.  Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform.

Authors:  Tianhong Dai; Beth B Fuchs; Jeffrey J Coleman; Renato A Prates; Christos Astrakas; Tyler G St Denis; Martha S Ribeiro; Eleftherios Mylonakis; Michael R Hamblin; George P Tegos
Journal:  Front Microbiol       Date:  2012-04-10       Impact factor: 5.640

8.  Defining the microbial effluxome in the content of the host-microbiome interaction.

Authors:  Anastasios Ioannidis; Maria Magana; Cristian G Bologa; Tudor I Oprea; Ian T Paulsen; George P Tegos
Journal:  Front Pharmacol       Date:  2015-02-19       Impact factor: 5.810

9.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22

10.  Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer.

Authors:  Y Yang; M M Huycke; T S Herman; X Wang
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.